KIM-1 as a circulating biomarker in metastatic RCC: Post-hoc analysis of JAVELIN Renal 101
Date:
Evaluation of circulating kidney injury molecule-1 (KIM-1) as a biomarker in metastatic RCC based on a post-hoc analysis of JAVELIN Renal 101.
Marc Machaalani, MD
Postdoctoral Research Fellow
- Boston, MA
- Dana-Farber Cancer Institute
- Google Scholar
- ORCID
- PubMed
- ResearchGate
- X (formerly Twitter)